Pardes Biosciences Analysis
Pardes Biosciences is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Pardes Biosciences delisted stock analysis is to determine its intrinsic value, which is an estimate of what Pardes Biosciences is worth, separate from its market price. There are two main types of Pardes Biosciences' stock analysis: fundamental analysis and technical analysis.
The Pardes Biosciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Pardes Biosciences is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Pardes Stock trading window is adjusted to America/New York timezone.
Pardes |
Pardes Stock Analysis Notes
About 13.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.37. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pardes Biosciences recorded a loss per share of 1.28. The entity had not issued any dividends in recent years. Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. The company was incorporated in 2020 and is headquartered in Carlsbad, California. Pardes Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 61 people. To find out more about Pardes Biosciences contact Thomas Wiggans at 415 649 8758 or learn more at https://www.pardesbio.com.Pardes Biosciences Investment Alerts
| Pardes Biosciences is not yet fully synchronised with the market data | |
| Pardes Biosciences has some characteristics of a very speculative penny stock | |
| Pardes Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (96.63 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Pardes Biosciences currently holds about 228.6 M in cash with (71.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.67. | |
| Roughly 72.0% of the company shares are owned by institutional investors |
Pardes Biosciences Upcoming and Recent Events
| 6th of November 2023 Upcoming Quarterly Report | View | |
| 12th of March 2024 Next Financial Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 12th of March 2024 Next Fiscal Year End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Pardes Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 133.95 M.Pardes Biosciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pardes Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pardes Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Pardes Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Henson Heidi over a year ago Disposition pursuant to a tender of shares in a change of control transaction by Henson Heidi of Pardes Biosciences | ||
Auerbach Mark over a year ago Acquisition by Auerbach Mark of 37500 shares of Pardes Biosciences subject to Rule 16b-3 | ||
Foresite Capital Management V Llc over a year ago Purchase by Foresite Capital Management V Llc of 773952 shares of Pardes Biosciences | ||
Sean Brusky over a year ago Acquisition by Sean Brusky of 156250 shares of Pardes Biosciences subject to Rule 16b-3 |
Pardes Biosciences Outstanding Bonds
Pardes Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pardes Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pardes bonds can be classified according to their maturity, which is the date when Pardes Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Pardes Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Pardes Stock
If you are still planning to invest in Pardes Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pardes Biosciences' history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |